Home > Publications > Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.

Zoledronic acid prevents bone loss after liver transplantation: a randomized, double-blind, placebo-controlled trial.

This paper reported the first double blinded control trial that showed that bone loss can be prevented post liver transplant and has defined the best practice in this area. This study was initiated and driven by GMcC and was the first study to prevent bone loss post liver transplantation.

Crawford, B. A., C. Kam, et al.

Ann Intern Med 2006;144: 239-48.

Date: 2006